LMAT
LeMaitre Vascular, Inc. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 4.45K | $354,298 | n/a | n/a |
| Q2 2026 | 98 | -4 | 14.59M | $1.39B | +4 | −8 |
| Q1 2026 | 105 | +6 | 13.61M | $1.47B | +7 | −1 |
| Q4 2025 | 99 | 0 | 13.36M | $1.08B | n/a | n/a |
| Q3 2025 | 17 | +1 | 7.95M | $695.46M | +1 | n/a |
| Q2 2025 | 13 | 0 | 7.07M | $587.26M | n/a | n/a |
| Q1 2025 | 10 | -2 | 2.25M | $188.56M | n/a | −2 |
| Q4 2024 | 12 | -1 | 2.09M | $192.81M | n/a | −1 |
| Q3 2024 | 12 | +2 | 1.29M | $120.13M | +2 | n/a |
| Q2 2024 | 10 | n/a | 1.21M | $99.82M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 4.45K | +24.0% | $354,298 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 337 holders, 21.96M shares, $2.32B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.